Printer Friendly

NEW BIOMEDICAL CONSORTIUM LAUNCHES COOPERATIVE VENTURES

 NEW BIOMEDICAL CONSORTIUM LAUNCHES COOPERATIVE VENTURES
 LINTHIEUM, Md., March 10 /PRNewswire/ -- In a pioneering enterprise, a dynamic group of diverse biomedical companies are pooling their resources and know-how to enhance their financial and operational capabilities. Under the aegis of the Washington-based Biomedical Entrepreneur Associates (BEA), a management firm, 11 companies from the United States and Canada are forming partnerships to create new projects for expansion of sales and new business in the market place.
 This kind of creative strategy is the answer to a sluggish and dispirited economy, BEA President and CEO Dr. Robert Friedenberg pointed out, as the consortium finalized seven collaborative transactions following a two-day conference of the members of the consortium. The unique "synergy" resulting from new configurations of companies gives strong impetus to these new ventures, he suggested.
 The transactions currently in development from operations in BEA are:
 1. Forming partnerships to move new technology (diagnostic tests on saliva) into new markets internationally.
 2. Meshing electronic telemonitoring security systems with computerized medical instrumentation and networks.
 3. Pilot plant development by one manufacturer for a line of cosmetics and natural foods from waste chicken feathers and feather meal from an R&D company.
 4. Joint ventures in government contract proposal submissions to health agencies by a large (20 M) health care consulting firm and a unique microcomputer company with software development and training specialists.
 5. Joint ventures/U.S. government proposal submissions by health care service companies with a minority-owned public relations, personnel-management, health-care company.
 6. Individual company brokerage financing developed for specific health product projects related to joint venture marketing.
 7. Unique marketing collaborative efforts headed by one company through national networking of partnerships and consultants in BEA to bring new health product technologies into new markets.
 Some of the subject companies tackling unique problems by the consortium which promise to have far-reaching effects in the biomedical field are:
 1. A diagnostic development company committed to the development of biosensors and saliva diagnostic testing kits.
 2. A diagnostic testing group devoted to the development of diagnostic instrumentation for monitoring ovulation in women.
 3. A non-invasive instrument testing company developing a clinical analyzer utilizing near infra-red technologies.
 4. A company developing gender diagnostic kits based on new chemical tests on urine.
 5. Two companies devoted to simple and accurate chemical tests for field diagnostics for alcohol and drugs of abuse.
 6. A company turning waste chicken feathers and meal into nutritional supplements, pharmaceuticals and cosmetics.
 7. An international biomedical marketing network company servicing physicians, hospitals, clinics and pharmacies in 20 different countries.
 Recognizing the broad interest that the biomedical and manufacturing communities have in the products of these collaborative ventures, BEA announced that it will keep its portfolio open to interested and qualified parties. The consortium is welcoming additional participation by interested persons, corporations and institutions.
 -0- 3/10/92
 /CONTACT: Edmund Jaskiewicz, chairman, Biomedical Entrepreneur Associates, Inc., 202-296-2295/ CO: Biomedical Entrepreneur Associates, Inc. ST: Maryland IN: MTC SU:


SB -- DC023 -- 6935 03/10/92 13:39 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 10, 1992
Words:501
Previous Article:APPLE'S QUICKTIME TO SUPPORT PHOTO CD IMAGES
Next Article:SNO COUNTRY REPORTS OFFICIAL SKI REPORT FOR APRIL 6, 1992
Topics:


Related Articles
'BRAIN POWER' HELPS MIDDLE SCHOOL STUDENTS MAKE HEALTHY CHOICES
HOFFMANN-LA ROCHE BECOMES FIRST TO JOIN JACKSON LABORATORY BIOINFORMATICS CONSORTIUM
TechEx Creates Internet Platform With Harvard and Its Affiliate Hospitals For Corporate Access to Biomedical Resources.
ID Biomedical signs option agreement with Discoverx to use cycling probe technology for genomics.
New Online Community for Life Science Industry Goes Live.
National Institutes of Health Symposium: Securing NIH Funding Support Sponsored by: New Jersey National Institute of Health Coordinating Council;...

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters